// App-Quantinova.ai

Mo1111 : Efficacy of Preoperative Administration of Ferric Carboxymaltose in Colon Cancer Patients and Anemia

Researchers

Presenter

  • Jose L. Calleja

Principal Investigators

  • Adolfo del Val

  • Mercedes Cucala

  • Fermin Mearin

  • Antonio J. Hervas Molina

  • Jose L. Larraona

  • Alvaro Teran

  • Jesus A. Varela

  • Teresa Broquetas

  • Francisco-Javier Esteban

  • Luis Ferrer Barcelo

  • Federico Arguelles-Arias

Medical Centers

  • Gastroenterology Unit, Hospital Nuestra Senora de Valme, Sevilla, Spain

  • Gastrointestinal Dpt., Centro Medico Teknon, Barcelona, Spain

  • Gastrointestinal Dpt., Hospital La Fe, Valencia, Spain

  • Gastrointestinal Dpt., Hospital Virgen de la Macarena, Sevilla, Spain

  • Gastrointestinal Dpt., Hospital Puerta de Hierro, Madrid, Spain

  • Medical Dpt., Vifor Pharma Espana, Barcelona, Spain

  • Gastrointestinal Dpt., Hospital La Paz, Madrid, Spain

  • Gastrointestinal Dpt., Hospital del Mar, Barcelona, Spain

  • Gastrointestinal Dpt., Hospital Reina Sofia, Cordoba, Spain

  • Gastrointestinal Dpt., Hospital General Universitario, Valencia, Spain

  • Gastrointestinal Dpt., Hospital Gregorio Maranon, Madrid, Spain

  • Gastrointestinal Surgery Dpt., Hospital Clinic, Barcelona, Spain

  • Gastrointestinal Dpt., Hospital Marques de Valdecilla, Santander, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Colorectal Cancer

  • Anemia

  • Solid malignancies

Biomarkers

  • Red Blood Cells

Drug/Treatment

  • Ferric carboxymaltose

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved